ACTUALITĂȚI ÎN PROFILAXIA ANTIRABICĂ. UN NOU VACCIN: VERORAB®

September 1, 1999

Mariana Mărdărescu *, Cristina Beldescu **
* Dr. Mariana Mărdărescu – medic primar, șef de secție la Institutul de Boli lnfecțioase “Prof. dr. Matei Balș, București
** Dr. Cristina Beldescu – medic specialist medicină generală Pasteur Merieux – Connaught – Rhone-Poulenc grup, București

Abstact

It is presented WHO Experts Committee on Rabies Recommendations, 1996. Since 1981 in our country it is in use a Rabies Vaccine prepared from virus grown in new born mouse brain. Quite frequent it was reported side effects like local allergic reactions or neurological reactions; the immunisation schedule is too long and many boosters are required. These failures may be avoided by using inactivated vaccine prepared from virus grown on VERO cells lines, like VERORAB® (Pasteur-Merieux-Connaught). There are presented some immunisation schedules using VERORAB® for prevention of rabies after animal bites (postexposure prophylaxis) according with rabies risk assessment; recommendations for using serum and rabies immune globulin there are also presented.

Previous Story

CONTROLUL DURERII NEOPLAZICE PRIN MORFINĂ CU ADMINISTRARE ORALĂ

Next Story

VALOAREA TERAPEUTICĂ ȘI SIGURANȚA UTILIZĂRII NUROFENULUI® (IBUPROFEN) ÎN TERAPEUTICA PEDIATRICĂ